Dr Reddys Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	500124	NSE Symbol:	DRREDDY	P/E :	14.7
ISIN Demat:	INE089A01031	Div & Yield %:	0.66	EPS :	82.6
Book Value:	345.76	Market Cap (Rs. Cr.):	101,305.71	Face Value :	1

Date	Headline
24-Jun-25	Dr Reddys Laboratories to hold board meeting
23-Jun-25	Dr Reddys Laboratories allots 10,685 equity shares under ESOP
16-Jun-25	Dr Reddys Laboratories allots Equity shares
05-Jun-25	Alvotech and Dr Reddy's enter into collaboration and license agreement for pembrolizumab
03-Jun-25	Dr Reddys Laboratories allots 57,840 equity shares under ESOS
17-May-25	USFDA completes GMP inspection of Dr Reddy's Middleburgh facility in New York
10-May-25	Dr Reddys Laboratories AGM scheduled
09-May-25	Board of Dr Reddys Laboratories recommends Final Dividend
24-Mar-25	Dr Reddys announces cessation of subsidiary in Louisiana
22-Mar-25	Dr Reddys Laboratories to conduct board meeting

Company Snapshot